InvestorsHub Logo
Followers 32
Posts 5818
Boards Moderated 0
Alias Born 05/23/2006

Re: None

Saturday, 07/27/2019 2:05:29 PM

Saturday, July 27, 2019 2:05:29 PM

Post# of 345964
Good article on CDMO competitor ....

one tidbit worth noting...

Also yesterday, the company announced plans to expand its bioconjugation facility in Visp, Switzerland, to meet increased demand and said it recently received approval for commercial manufacturing of a third antibody-drug conjugate.

The expansion will take two years, and contracts are already in place for the extra capacity, according to Lonza. The facility "will provide current and future customers with launch and commercial manufacturing and will serve the rapidly expanding early clinical phase market for bioconjugates," the company said

https://www.biopharmadive.com/news/lonza-plans-facility-expansion-amid-pharma-focus/559541/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News